Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient.
Document Type
Article
Abstract
Botulinum toxin A is commonly used to reduce spasticity and dystonia in children with cerebral palsy. We report a pediatric patient who developed systemic botulism as a result of a severe overdose of the injected toxin (40 U/kg). This case highlights the importance of physicians having adequate knowledge of primate and human literature on the lethal dose, 50% of botulinum toxin A before injecting children.
Medical Subject Headings
Botulinum Toxins, Type A; Botulism; Cerebral Palsy; Child, Preschool; Female; Humans
Publication Date
9-1-2007
Publication Title
Clinical neuropharmacology
ISSN
0362-5664
Volume
30
Issue
5
First Page
310
Last Page
313
PubMed ID
17909312
Digital Object Identifier (DOI)
10.1002/mds.20919
Recommended Citation
Crowner, Beth E; Brunstrom, Janice E; and Racette, Brad A, "Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient." (2007). Neurology. 1207.
https://scholar.barrowneuro.org/neurology/1207